Company Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.
The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.
The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products.
It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels.
The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.
Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 10, 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 560 |
| CEO | Ronald M. Lombardi |
Contact Details
Address: 660 White Plains Rd. Tarrytown, New York 10591 United States | |
| Phone | (914) 524-6800 |
| Website | prestigebrands.com |
Stock Details
| Ticker Symbol | PBH |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001295947 |
| CUSIP Number | 74112D101 |
| ISIN Number | US74112D1019 |
| Employer ID | 20-1297589 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ronald M. Lombardi | Chairman, President and Chief Executive Officer |
| Christine Sacco | Chief Financial Officer |
| Jeffrey Zerillo | Senior Vice President of Operations |
| William C. P'Pool | Senior Vice President, General Counsel and Corporate Secretary |
| Adel Mekhail | Executive Vice President of Marketing and Sales |
| Philip David Terpolilli | Director of Investor Relations |
| Dean Siegal | Director of Communications |
| Mary Beth Fritz | Senior Vice President of Quality and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 1, 2024 | 144 | Filing |
| Feb 28, 2024 | 144 | Filing |
| Feb 27, 2024 | 144 | Filing |
| Feb 26, 2024 | 144 | Filing |
| Feb 23, 2024 | 144 | Filing |
| Feb 15, 2024 | 144 | Filing |
| Feb 14, 2024 | 144 | Filing |
| Feb 14, 2024 | 144 | Filing |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |